Icon

RITALIN (nda010187)- (5MG,10MG,20MG)

METHYLPHENIDATE HYDROCHLORIDE SANDOZ
5MG,10MG,20MG
No No
Expired Expired
None None
None No
Ritalin is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorders (ADHD) and Narcolepsy.
12 1 10
Total Other Developers 3
Drugs with Suitability No
5MG ** ** - 8 1
10MG ** ** Up 8 1
20MG ** ** Up 8 1
NDA Sales Available Total Generic Sales Available
Yes 9
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** *** ****** *** *********** *** ******** ****** *.*. *** *, ******, *** **** (**) *****, ****** ****** (***) ***
****** ****** *** ****** *** *** *********** **** *. *** ******, **. *****, ******** (**) *****, ****** ****** (***) ***
****** *** ***** **** *** *** ************ ***. *********** ** ******** ****, *** *********, *** ****** (**) *****, ****** ****** (***) ***
****** ******** ****** *************** ** *** ****, *** *********** ** ********** **, **********, *** **** (**) *****-****, ****** ****** (***) ***
****** ******** ********, *.*. *** *********** **** ***** *****, **** ********, *** ****** (**) *****, ****** ****** (***) ***
****** ***** *** ***-****, ***. *********** *** ***** **., *******, ************ (**) *****, ****** ****** (***) ***
****** ****** ****** *** ****** *************** *** *********** *** * ********** **, ******* *****, *** **** (**) *****, ****** ****** (***) ***
****** ***** **** *** ***** ************, ***. *********** *** ****** *****, ********, *** ****** (**) *****, ****** ****** (***) ***
****** ***** **** *** ***** ************ ******* *********** **** **. ***/*, ***, ***/*, ***/* & ***/* ******* ****** ***** *****, *******, *****, ***** & *** ******, ***** (***) ***
****** ***** **** *** *&* ****** *** *** ***** ************ *********** **** ******* **, ******, ******** (**) *****-****, ****** ****** (***) ***
****** ******** *** ******** ***** ** *** */*/* ******** ************ *********** **** ******** ****., *********, ***** ******** (**) *****, ****** ****** (***) ***
****** ****** ******** *** ****** *** *********** **** **** *****, ***********, ******** (**) *****, ****** ****** (***) ***
****** ******** *** **********, ***. *********** ** ******** ******, ******, ****** **** (**) *****, ****** ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.